共 50 条
- [21] Capecitabine and lapatinib for the first-line treatment of metastatic/recurrent head and neck squamous cell carcinomaCANCER, 2016, 122 (15) : 2350 - 2355Weiss, Jared M.论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Lineberger Comprehens Canc Ctr, Div Hematol & Oncol, Chapel Hill, NC USA Univ N Carolina, Lineberger Comprehens Canc Ctr, Div Hematol & Oncol, Chapel Hill, NC USABagley, Stephen论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Abramson Comprehens Canc Ctr, Div Hematol & Oncol, Philadelphia, PA 19104 USA Univ N Carolina, Lineberger Comprehens Canc Ctr, Div Hematol & Oncol, Chapel Hill, NC USAHwang, Wei-Ting论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA Univ N Carolina, Lineberger Comprehens Canc Ctr, Div Hematol & Oncol, Chapel Hill, NC USABauml, Joshua论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Abramson Comprehens Canc Ctr, Div Hematol & Oncol, Philadelphia, PA 19104 USA Univ N Carolina, Lineberger Comprehens Canc Ctr, Div Hematol & Oncol, Chapel Hill, NC USAOlson, Juneko Grilley论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Lineberger Comprehens Canc Ctr, Div Hematol & Oncol, Chapel Hill, NC USA Univ N Carolina, Lineberger Comprehens Canc Ctr, Div Hematol & Oncol, Chapel Hill, NC USACohen, Roger B.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Abramson Comprehens Canc Ctr, Div Hematol & Oncol, Philadelphia, PA 19104 USA Univ N Carolina, Lineberger Comprehens Canc Ctr, Div Hematol & Oncol, Chapel Hill, NC USAHayes, David Neil论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Lineberger Comprehens Canc Ctr, Div Hematol & Oncol, Chapel Hill, NC USA Univ N Carolina, Lineberger Comprehens Canc Ctr, Div Hematol & Oncol, Chapel Hill, NC USALanger, Corey论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Abramson Comprehens Canc Ctr, Div Hematol & Oncol, Philadelphia, PA 19104 USA Univ N Carolina, Lineberger Comprehens Canc Ctr, Div Hematol & Oncol, Chapel Hill, NC USA
- [22] Paradigm Change in First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell CarcinomaCANCERS, 2021, 13 (11)Borcoman, Edith论文数: 0 引用数: 0 h-index: 0机构: Inst Curie, Dept Drug Dev & Innovat D3i, F-75005 Paris, France Inst Curie, Dept Drug Dev & Innovat D3i, F-75005 Paris, FranceMarret, Gregoire论文数: 0 引用数: 0 h-index: 0机构: Inst Curie, Dept Drug Dev & Innovat D3i, F-75005 Paris, France Inst Curie, Dept Drug Dev & Innovat D3i, F-75005 Paris, FranceLe Tourneau, Christophe论文数: 0 引用数: 0 h-index: 0机构: Inst Curie, Dept Drug Dev & Innovat D3i, F-75005 Paris, France INSERM U900 Res Unit, F-92210 St Cloud, France Paris Saclay Univ, Versailles St Quentin En Yvelines Univ, Fac Med, F-78180 Montigny Le Bretonneux, France Inst Curie, Dept Drug Dev & Innovat D3i, F-75005 Paris, France
- [23] A multicenter, retrospective study analysis: Evaluating the efficacy and safety of pembrolizumab in the first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma.JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Hu, Man论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R ChinaZhang, Shichuan论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R ChinaHan, Yaqian论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R ChinaWu, Hui论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R ChinaGao, Jin论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R ChinaWu, Haijun论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R ChinaLin, Qin论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R ChinaShang, Wei论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R ChinaLi, Xia论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R ChinaFeng, Hong论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R ChinaQiao, Qiao论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R ChinaHu, Guangyuan论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R ChinaYang, Kunyu论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R ChinaSong, Xicheng论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R ChinaCao, Yuandong论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R ChinaKang, Min论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R ChinaWang, Ruozheng论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R ChinaYu, Jinming论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R China
- [24] Correlative and spatial biomarker analysis of a phase 1/2b study to evaluate pepinemab in combination with pembrolizumab for first-line treatment of patients with recurrent or metastatic head and neck cancerJOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Evans, Elizabeth E.论文数: 0 引用数: 0 h-index: 0机构: Vaccinex Inc, Rochester, NY USAFisher, Terrence Lee论文数: 0 引用数: 0 h-index: 0机构: Vaccinex Inc, Rochester, NY USAMallow, Crystal L.论文数: 0 引用数: 0 h-index: 0机构: Vaccinex Inc, Rochester, NY USAFoster, Amber论文数: 0 引用数: 0 h-index: 0机构: Vaccinex Inc, Rochester, NY USALeonard, John E.论文数: 0 引用数: 0 h-index: 0机构: Vaccinex Inc, Rochester, NY USAChaney, Marya F.论文数: 0 引用数: 0 h-index: 0机构: Vaccinex Inc, Rochester, NY USAMekhail, Tarek论文数: 0 引用数: 0 h-index: 0机构: Vaccinex Inc, Rochester, NY USASeetharamu, Nagashree论文数: 0 引用数: 0 h-index: 0机构: Vaccinex Inc, Rochester, NY USASteuer, Conor Ernst论文数: 0 引用数: 0 h-index: 0机构: Vaccinex Inc, Rochester, NY USASaba, Nabil F.论文数: 0 引用数: 0 h-index: 0机构: Vaccinex Inc, Rochester, NY USAAdkins, Douglas论文数: 0 引用数: 0 h-index: 0机构: Vaccinex Inc, Rochester, NY USABeck, J. Thaddeus论文数: 0 引用数: 0 h-index: 0机构: Vaccinex Inc, Rochester, NY USAAlgazi, Alain Patrick论文数: 0 引用数: 0 h-index: 0机构: Vaccinex Inc, Rochester, NY USABurtness, Barbara论文数: 0 引用数: 0 h-index: 0机构: Vaccinex Inc, Rochester, NY USABaumgart, Megan论文数: 0 引用数: 0 h-index: 0机构: Vaccinex Inc, Rochester, NY USAGiampoli, Ellen论文数: 0 引用数: 0 h-index: 0机构: Vaccinex Inc, Rochester, NY USAHager, Steven Jeffrey论文数: 0 引用数: 0 h-index: 0机构: Vaccinex Inc, Rochester, NY USAChay, Christopher H.论文数: 0 引用数: 0 h-index: 0机构: Vaccinex Inc, Rochester, NY USASpira, Alexander I.论文数: 0 引用数: 0 h-index: 0机构: Vaccinex Inc, Rochester, NY USAZauderer, Maurice论文数: 0 引用数: 0 h-index: 0机构: Vaccinex Inc, Rochester, NY USA
- [25] Phase 2 study of dalantercept in recurrent or metastatic squamous cell carcinoma of the head and neckJOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)Jimeno, Antonio论文数: 0 引用数: 0 h-index: 0机构: Univ Colorado Denver, Aurora, CO USAPosner, Marshall R.论文数: 0 引用数: 0 h-index: 0机构: Univ Colorado Denver, Aurora, CO USAWeiss, Jared论文数: 0 引用数: 0 h-index: 0机构: Univ Colorado Denver, Aurora, CO USAWirth, Lori J.论文数: 0 引用数: 0 h-index: 0机构: Univ Colorado Denver, Aurora, CO USASaba, Nabil F.论文数: 0 引用数: 0 h-index: 0机构: Univ Colorado Denver, Aurora, CO USACohen, Roger B.论文数: 0 引用数: 0 h-index: 0机构: Univ Colorado Denver, Aurora, CO USAPopa, Elizabeta C.论文数: 0 引用数: 0 h-index: 0机构: Univ Colorado Denver, Aurora, CO USAArgiris, Athanassios论文数: 0 引用数: 0 h-index: 0机构: Univ Colorado Denver, Aurora, CO USAGrossmann, Kenneth F.论文数: 0 引用数: 0 h-index: 0机构: Univ Colorado Denver, Aurora, CO USASukari, Ammar论文数: 0 引用数: 0 h-index: 0机构: Univ Colorado Denver, Aurora, CO USAKorth, Chris论文数: 0 引用数: 0 h-index: 0机构: Univ Colorado Denver, Aurora, CO USAWilson, Dawn论文数: 0 引用数: 0 h-index: 0机构: Univ Colorado Denver, Aurora, CO USAMcClure, Ty论文数: 0 引用数: 0 h-index: 0机构: Univ Colorado Denver, Aurora, CO USAAlimzhanov, Marat论文数: 0 引用数: 0 h-index: 0机构: Univ Colorado Denver, Aurora, CO USAPearsall, Scott论文数: 0 引用数: 0 h-index: 0机构: Univ Colorado Denver, Aurora, CO USAAttie, Kenneth M.论文数: 0 引用数: 0 h-index: 0机构: Univ Colorado Denver, Aurora, CO USASherman, Matthew L.论文数: 0 引用数: 0 h-index: 0机构: Univ Colorado Denver, Aurora, CO USAPandya, Shuchi Sumant论文数: 0 引用数: 0 h-index: 0机构: Univ Colorado Denver, Aurora, CO USA
- [26] Cost-effectiveness of pembrolizumab as monotherapy or in combination with chemotherapy versus EXTREME regimen for the first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma in TaiwanANNALS OF ONCOLOGY, 2020, 31 : S1349 - S1349Wang, C. H.论文数: 0 引用数: 0 h-index: 0机构: Chang Gung Mem Hosp, Hematol Oncol, Keelung, Taiwan Chang Gung Mem Hosp, Hematol Oncol, Keelung, TaiwanLei, H. L.论文数: 0 引用数: 0 h-index: 0机构: MSD LLC Taiwan Branch, Market Access & Policy, Taipei, Taiwan Chang Gung Mem Hosp, Hematol Oncol, Keelung, TaiwanBorse, R.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Ctr Observat & Real World Evidence, Kenilworth, NJ USA Chang Gung Mem Hosp, Hematol Oncol, Keelung, TaiwanChirovsky, D.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Ctr Observat & Real World Evidence, Kenilworth, NJ USA Chang Gung Mem Hosp, Hematol Oncol, Keelung, TaiwanChien, L.论文数: 0 引用数: 0 h-index: 0机构: MSD LLC Taiwan Branch, Market Access & Policy, Taipei, Taiwan Chang Gung Mem Hosp, Hematol Oncol, Keelung, TaiwanTan, S. C.论文数: 0 引用数: 0 h-index: 0机构: MSD Int GmbH, Market Access Oncol, Singapore, Singapore Chang Gung Mem Hosp, Hematol Oncol, Keelung, TaiwanSpiteri, C.论文数: 0 引用数: 0 h-index: 0机构: CORE Asia Pacific, Oncol, Castle Hill, Australia Chang Gung Mem Hosp, Hematol Oncol, Keelung, Taiwan
- [27] Pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma in an Asian populationMEDICINE, 2017, 96 (52)Chen, Wen-Chun论文数: 0 引用数: 0 h-index: 0机构: Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan Natl Yang Ming Univ, Sch Med, Taipei, Taiwan Taipei Vet Gen Hosp, Dept Med, Taipei, TaiwanChu, Pen-Yuan论文数: 0 引用数: 0 h-index: 0机构: Taipei Vet Gen Hosp, Dept Otolaryngol, Taipei, Taiwan Taipei Vet Gen Hosp, Dept Med, Taipei, TaiwanLee, Yu-Ting论文数: 0 引用数: 0 h-index: 0机构: Natl Yang Ming Univ, Sch Med, Taipei, Taiwan Taichung Vet Gen Hosp, Chiayi Branch, Dept Med, Chiayi, Taiwan Taipei Vet Gen Hosp, Dept Med, Taipei, TaiwanLu, Wen-Bin论文数: 0 引用数: 0 h-index: 0机构: Jiangsu Univ, Wujin Peoples Hosp, Dept Med Oncol, Wujin, Jiangsu, Peoples R China Taipei Vet Gen Hosp, Dept Med, Taipei, TaiwanLiu, Chun-Yu论文数: 0 引用数: 0 h-index: 0机构: Natl Yang Ming Univ, Sch Med, Taipei, Taiwan Taipei Vet Gen Hosp, Dept Oncol, Div Med Oncol, 201,Sec 2,Shih Pai Rd, Taipei 112, Taiwan Taipei Vet Gen Hosp, Dept Med, Taipei, TaiwanChang, Peter Mu-Hsin论文数: 0 引用数: 0 h-index: 0机构: Natl Yang Ming Univ, Sch Med, Taipei, Taiwan Taipei Vet Gen Hosp, Dept Oncol, Div Med Oncol, 201,Sec 2,Shih Pai Rd, Taipei 112, Taiwan Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan论文数: 引用数: h-index:机构:
- [28] A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland CancerCLINICAL CANCER RESEARCH, 2020, 26 (04) : 837 - 845Rodriguez, Cristina P.论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Dept Med, Div Oncol, Seattle, WA 98109 USA Univ Washington, Dept Med, Div Oncol, Seattle, WA 98109 USAWu, Qian论文数: 0 引用数: 0 h-index: 0机构: Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, 1124 Columbia St, Seattle, WA 98104 USA Univ Washington, Dept Med, Div Oncol, Seattle, WA 98109 USAVoutsinas, Jenna论文数: 0 引用数: 0 h-index: 0机构: Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, 1124 Columbia St, Seattle, WA 98104 USA Univ Washington, Dept Med, Div Oncol, Seattle, WA 98109 USAFromm, Jonathan R.论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Dept Lab Med, Seattle, WA 98109 USA Univ Washington, Dept Med, Div Oncol, Seattle, WA 98109 USAJiang, Xiuyun论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Dept Surg, Seattle, WA 98109 USA Univ Washington, Dept Med, Div Oncol, Seattle, WA 98109 USAPillarisetty, Venu G.论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Dept Surg, Seattle, WA 98109 USA Univ Washington, Dept Med, Div Oncol, Seattle, WA 98109 USALee, Sylvia M.论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Dept Med, Div Oncol, Seattle, WA 98109 USA Univ Washington, Dept Med, Div Oncol, Seattle, WA 98109 USASantana-Davila, Rafael论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Dept Med, Div Oncol, Seattle, WA 98109 USA Univ Washington, Dept Med, Div Oncol, Seattle, WA 98109 USAGoulart, Bernardo论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Dept Med, Div Oncol, Seattle, WA 98109 USA Univ Washington, Dept Med, Div Oncol, Seattle, WA 98109 USABaik, Christina S.论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Dept Med, Div Oncol, Seattle, WA 98109 USA Univ Washington, Dept Med, Div Oncol, Seattle, WA 98109 USAChow, Laura Q. M.论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Dept Med, Div Oncol, Seattle, WA 98109 USA Univ Washington, Dept Med, Div Oncol, Seattle, WA 98109 USAEaton, Keith论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Dept Med, Div Oncol, Seattle, WA 98109 USA Univ Washington, Dept Med, Div Oncol, Seattle, WA 98109 USAMartins, Renato论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Dept Med, Div Oncol, Seattle, WA 98109 USA Univ Washington, Dept Med, Div Oncol, Seattle, WA 98109 USA
- [29] Phase II study of dasatinib in combination with cetuximab in recurrent/metastatic head and neck squamous cell carcinomaCANCER RESEARCH, 2016, 76Stabile, Laura P.论文数: 0 引用数: 0 h-index: 0Egloff, Ann Marie论文数: 0 引用数: 0 h-index: 0Zhou, Pei论文数: 0 引用数: 0 h-index: 0Gooding, William E.论文数: 0 引用数: 0 h-index: 0Grandis, Jennifer R.论文数: 0 引用数: 0 h-index: 0Bauman, Julie E.论文数: 0 引用数: 0 h-index: 0
- [30] Effects of Pembrolizumab in Recurrent/Metastatic Squamous Cell Head and Neck Carcinoma: A Multicenter Retrospective StudyANTICANCER RESEARCH, 2023, 43 (06) : 2717 - 2724Okada, Takuro论文数: 0 引用数: 0 h-index: 0机构: Tokyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Tokyo, Japan Tokyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, 6-7-1 Nishishinjuku,Shinjuku ku, Tokyo 1600023, Japan Tokyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Tokyo, JapanFushimi, Chihiro论文数: 0 引用数: 0 h-index: 0机构: Int Univ Hlth, Welf Mita Hosp, Dept Head & Neck Oncol & Surg, Tokyo, Japan Tokyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Tokyo, JapanMatsuki, Takashi论文数: 0 引用数: 0 h-index: 0机构: Kitasato Univ, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Sagamihara, Japan Tokyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Tokyo, JapanTokashiki, Kunihiko论文数: 0 引用数: 0 h-index: 0机构: Tokyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Tokyo, Japan Tokyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Tokyo, JapanTakahashi, Hideaki论文数: 0 引用数: 0 h-index: 0机构: Yokohama City Univ, Dept Otorhinolaryngol, Head & Neck Surg, Yokohama, Japan Tokyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Tokyo, JapanOkamoto, Isaku论文数: 0 引用数: 0 h-index: 0机构: Tokyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Tokyo, Japan Tokyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Tokyo, JapanSato, Hiroki论文数: 0 引用数: 0 h-index: 0机构: Tokyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Tokyo, Japan Tokyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Tokyo, JapanKondo, Takahito论文数: 0 引用数: 0 h-index: 0机构: Tokyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Hachioji Med Ctr, Tokyo, Japan Tokyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Tokyo, JapanHanyu, Kenji论文数: 0 引用数: 0 h-index: 0机构: Tokyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Tokyo, Japan Tokyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Tokyo, JapanKishida, Takuma论文数: 0 引用数: 0 h-index: 0机构: Tokyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Tokyo, Japan Tokyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Tokyo, JapanIto, Tatsuya论文数: 0 引用数: 0 h-index: 0机构: Tokyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Tokyo, Japan Tokyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Tokyo, JapanYamashita, Gai论文数: 0 引用数: 0 h-index: 0机构: Tokyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Tokyo, Japan Tokyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Tokyo, JapanMasubuchi, Tatsuo论文数: 0 引用数: 0 h-index: 0机构: Int Univ Hlth, Welf Mita Hosp, Dept Head & Neck Oncol & Surg, Tokyo, Japan Tokyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Tokyo, Japan论文数: 引用数: h-index:机构:Miura, Koki论文数: 0 引用数: 0 h-index: 0机构: Int Univ Hlth, Welf Mita Hosp, Dept Head & Neck Oncol & Surg, Tokyo, Japan Tokyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Tokyo, JapanOmura, Go论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Dept Head & Neck Oncol, Tokyo, Japan Tokyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Tokyo, JapanYamashita, Taku论文数: 0 引用数: 0 h-index: 0机构: Kitasato Univ, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Sagamihara, Japan Tokyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Tokyo, JapanOridate, Nobuhiko论文数: 0 引用数: 0 h-index: 0机构: Yokohama City Univ, Dept Otorhinolaryngol, Head & Neck Surg, Yokohama, Japan Tokyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Tokyo, JapanTsukahara, Kiyoaki论文数: 0 引用数: 0 h-index: 0机构: Tokyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Tokyo, Japan Tokyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Tokyo, Japan